PEEP as Rescue Therapy for Asthmatics With Elevated BMI

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the effect of increasing lung volume with a simple hand-held device to both prevent, and also to relieve, airway constriction in people with asthma and a BMI ≥ 30 kg/m2.

Twenty people with late onset non-allergic asthma and a BMI of ≥ 30 kg/m2 will be recruited. The efficacy of elevating lung volume on both preventing and reversing bronchoconstriction will be tested. Lung volume will be modulated by breathing out against a small level of resistance (positive expiratory pressure).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of PEEP on Heart and Lungs in Obese Subjects

NCT02523352

Obesity Pulmonary Atelectasis Obesity Hypoventilation Syndrome +4 more

UNKNOWN NA

Providing Optimal PEEP During Mechanical Ventilation for Obese Patients Using Esophageal Balloon

NCT03951064

Obesity, Morbid Ventilator-Induced Lung Injury Respiratory Failure

TERMINATED NA

EIT Assessment of Lung Volume and Tidal Distribution: A Comparison of Non-Invasive Ventilation Devices

NCT02930174

Spontaneous Ventilation

COMPLETED NA

GO2 PEEP Study: Bidirectional Oxygenation Valve in Postoperative Atelectasis

NCT04253834

Postoperative Atelectasis

COMPLETED NA

Using Ultrasound to Study Respiratory Muscle Function in Critically Ill Patients

NCT03139695

Injury of Diaphragm Mechanical Ventilation Complication Critical Illness

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will investigate whether PEEP can prevent and/or reverse bronchoconstriction in asthmatics with a BMI \> 30 kg/m2.

People with late-onset non-allergic asthma that develops in the setting of obesity do not respond well to conventional asthma medications, likely because all treatments for asthma have been developed to treat early-onset allergic disease in lean patients. There is a critical need to understand the pathophysiology of airway disease in late-onset, non-allergic obese asthmatics, in order to develop therapies to target this disease.

Airway hyperresponsiveness (AHR) is a defining characteristic in asthma. Lung function tests in individuals with late onset asthma in the setting of obesity are suggestive of distal airway closure rather than airway narrowing as a cause of hyperresponsiveness; these individuals tend to have more collapsible lung peripheries than obese individuals who do not develop asthma. If late onset asthma in obesity is related to a tendency of airways to close, it should respond to therapies designed to keep airways open, such as Positive End-Expiratory Pressure (PEEP).

The purpose of this study is to investigate the efficacy of PEEP on prevention and reversal of bronchoconstriction in obese people with asthma. This will be achieved by investigating the efficacy of PEEP therapy on preventing and reversing bronchoconstriction in response to the inhalation of methacholine, while measuring changes in respiratory impedance using the forced oscillation method.

Participants will initially perform a conventional methacholine challenge test.

Participants will return for 2 visits in which methacholine will be administered concurrently with varying levels of PEEP (using PEEP to prevent bronchoconstriction) while measuring changes in respiratory impedance using the forced oscillation method.

Participants will return for another 2 visits in which PEEP will be administered subsequent to methacholine challenge (using PEEP to reverse bronchoconstriction) while measuring changes in respiratory impedance using the forced oscillation method.

These studies will be completed over 5 visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rescue

Intervention: Positive expiratory pressure (PEEP) 10 will be applied after the administration of methacholine

Group Type EXPERIMENTAL

Positive Expiratory Pressure

Intervention Type DEVICE

Patient will exhale against positive expiratory pressure 0 mm or 10 mm while inhaling methacholine

Prophylaxis

Intervention: Positive expiratory pressure (PEEP) 10 will be applied during the administration of methacholine

Group Type EXPERIMENTAL

Positive Expiratory Pressure

Intervention Type DEVICE

Patient will exhale against positive expiratory pressure 0 mm or 10 mm while inhaling methacholine

No PEEP

Intervention: Positive expiratory pressure (PEEP) 0 will be applied during the administration of methacholine

Group Type PLACEBO_COMPARATOR

Positive Expiratory Pressure

Intervention Type DEVICE

Patient will exhale against positive expiratory pressure 0 mm or 10 mm while inhaling methacholine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Positive Expiratory Pressure

Patient will exhale against positive expiratory pressure 0 mm or 10 mm while inhaling methacholine

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PEEP

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PC20 to methacholine \< 16 mg/ml
* Asthma diagnosis when ≥ 18 years of age
* Serum Immunoglobulin E \< 100 IU/ml
* Ages ≥ 18 years
* BMI ≥ 30 kg/m2

Exclusion Criteria

* Asthma exacerbation (defined as a hospitalization, ED visit, urgent care visit for asthma or new corticosteroids for asthma) in prior 6 weeks.
* Forced Expiratory Volume in 1 second \< 60 % predicted
* Other significant disease that in the opinion of the investigator would interfere with study
* Inability to perform required testing.
* Smoking within last 6 months.
* ≥ 20 pack year smoking history
* Inability to provide informed consent
* Pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No